GLUT1 as a therapeutic target in hepatocellular carcinoma.
about
Molecular basis of ligand recognition and transport by glucose transportersSLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanismsCrystal structure of a bacterial homologue of glucose transporters GLUT1-4Crystal structure of the human glucose transporter GLUT1Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amidesDehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CTLiverome: a curated database of liver cancer-related gene signatures with self-contained context informationMetabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetesDoes expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells.PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinomaIdentification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature.Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cellsActivating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.Specific protein 1 depletion attenuates glucose uptake and proliferation of human glioma cells by regulating GLUT3 expression.Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose.Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.TSdb: a database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates.GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.Osthole activates glucose uptake but blocks full activation in L929 fibroblast cells, and inhibits uptake in HCLE cells.Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.Differential regulation of GLUT1 activity in human corneal limbal epithelial cells and fibroblasts.Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiencyEssential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism.Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?Molecular Pathogenesis of Hepatocellular Carcinoma.miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1.
P2860
Q24338453-6E3D9DAC-EBFC-4046-B833-C35236550550Q26749468-2C074DD2-F872-4696-A422-C126CA27F19EQ27682874-FB800346-3AC7-4E20-9E7B-10217069174BQ27690274-D6C42E62-B2A2-476D-BE74-9EC923019049Q28833619-F2A9CEF1-AC2B-4FF7-BFF1-FBBCE5AE5045Q33681427-0BE9F2D8-3CF4-43EC-ABCC-9FACDABE1799Q33739782-EB187200-6FA8-4A3C-8CE4-FC03537CC570Q33798559-2634B8D6-F1D6-4EBD-88E1-A05D1793B415Q34173509-725C7A95-6FA0-41E1-9BBC-AB3A1246322CQ34193811-A3BCBFC7-15F6-44C4-9388-2564FC7DB8D1Q34756307-A29AA2A4-902B-4A85-8244-95FF8FAEC0B1Q35015365-C83BC74E-EF64-424E-B042-D3DEF3BF83B9Q35335157-BE6BB879-7480-4E20-BAA6-E99F5F861F60Q35536490-375EFFA8-A7F7-48BC-BB25-C4E3B59D6CE1Q35598807-DFCD2918-C669-4BB9-8A08-D466D8E078D0Q35793653-1881E135-71AB-44FB-A012-79DF745CA056Q36110504-19E057F7-4267-48EF-8935-A5EE5EEB77DEQ36454678-9F3437CC-79D8-4A0A-BC05-B7B419A6A77AQ36544964-7B919CAF-429F-4920-8350-383633571BC3Q36557906-634C6F34-7D7C-4590-91D8-72E4BCADD720Q36792366-9BD966D5-1647-4BD5-B130-7BE014448C5CQ37001138-3F13FC24-E2D5-4C78-BFEC-A23808D50129Q37187702-84F3F66F-D9C4-4882-9AB4-FD4D9A65CA33Q37412531-A892433B-9BB2-490B-B0CD-F9C577DF9D61Q37580206-D26CC444-A5C3-442C-9D3B-84A3BC8F3AF4Q37598464-C640B9A7-2B73-47FB-9B1F-3803BFFB47C6Q38213800-E1D52237-7022-4C23-8B0D-7B64F48853C6Q38401664-1CC9CC19-D007-4640-B897-999C30292679Q38435352-C318EDFB-0759-4CDC-9EC0-620599A873C2Q38495617-8650E297-EAF5-45F7-ACA9-952189EFD06BQ38663958-C6A6DFDF-19D9-4100-AA7F-A04485E1E709Q38788907-05576CDD-D08D-403B-99F1-A1F65A30DF05Q39012937-FFBD355E-C13C-41FB-BDA6-417131ABC07FQ39083283-5F8A5D78-0607-4AD2-B60D-ABD92CBD422CQ39272087-7C088D2E-7794-4F6E-BB56-BBDD93FFEC8FQ39912175-AABB3762-C7BB-4A20-B116-4D8A79AC0346Q40950194-5C12C587-B885-414F-BE49-CD42E59C2F6FQ41493120-8C81D0A7-D175-4A31-9CE7-2BA33B37ADE3Q41544729-8AA24FF8-706B-4917-A92D-1429EFA0F7B8Q42215399-BFD53AED-665D-437C-A37E-2381A7703774
P2860
GLUT1 as a therapeutic target in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@en
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@nl
type
label
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@en
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@nl
prefLabel
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@en
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@nl
P2860
P1476
GLUT1 as a therapeutic target in hepatocellular carcinoma.
@en
P2093
Claus Hellerbrand
Thomas Amann
P2860
P304
P356
10.1517/14728220903307509
P407
P577
2009-12-01T00:00:00Z